Onconomics

What is Onconomics?

Onconomics is the RGCC Liquid Biopsy Profile in which it combines the evaluation of the Gene Expression Profile at the Epigenetic Level and Chemosensitivity for Cytotoxic Drugs (Chemotherapeutics)

Chemistry-Sensitivity, Epigenetic Analysis and Feasibility Tests (ONCONOMICS)

Epigenetic Analysis allows us to really analyze how malignant cells grow, multiply, develop new blood vessels, proliferate in other regions (metastases), which feed them and inhibit them. This result is validated with the viability assay, since the rate of gene expression does not always have a linear relation with the protein phenotype. Therefore, in micro-cultures, we confirm the viability of the cells when exposed to the active form of each drug by the Chemistry-Sensitivity. The feasibility diagram below represents the percentage of viable cells compared to the primary population.

Result Models:

The results of Onconomics allow the Physician and the Patient, a decision making for treatment based on: Epigenetic Analysis and Chemistry-Sensitivity for Targets and Target Therapies

For a better use, the results should be:

• Scientifically based and complete
• Easy to Read and to Understand by a Non-Specialist
• Easy to Play